Nephrology Dialysis Transplantation最新文献

ABCDE to identify and prevent chronic kidney disease: a call to action.

IF 4.8 2区医学

Nephrology Dialysis Transplantation Pub Date : 2025-03-19 DOI: 10.1093/ndt/gfaf057

Charles J Ferro, Christoph Wanner, Valerie Luyckx, Kate Stevens, Sofia Cerqueira, Rasha Darwish, Beatriz Fernandez Fernandez, David Fiel, Rumen Filev, Manfred Grieger, Antonia Lopez, Merike Luman, Jolanta Malyszko, Milena Krasimirova Nikolova-Vlahova, Fiita Romero, Chrysanthi Skalioti, Carla Alexandra Ribeiro Dos Santos Araújo, Ieva Ziedina, Daniel Gallego, Alberto Ortiz, Roser Torra, Raymond Vanholder

{"title":"ABCDE to identify and prevent chronic kidney disease: a call to action.","authors":"Charles J Ferro, Christoph Wanner, Valerie Luyckx, Kate Stevens, Sofia Cerqueira, Rasha Darwish, Beatriz Fernandez Fernandez, David Fiel, Rumen Filev, Manfred Grieger, Antonia Lopez, Merike Luman, Jolanta Malyszko, Milena Krasimirova Nikolova-Vlahova, Fiita Romero, Chrysanthi Skalioti, Carla Alexandra Ribeiro Dos Santos Araújo, Ieva Ziedina, Daniel Gallego, Alberto Ortiz, Roser Torra, Raymond Vanholder","doi":"10.1093/ndt/gfaf057","DOIUrl":"https://doi.org/10.1093/ndt/gfaf057","url":null,"abstract":"Kidney disease is a global health priority affecting over 850 million people worldwide. This number is projected to increase over the coming decades given the increasing prevalence of diabetes, hypertension and obesity, and the aging population. Chronic kidney disease can reduce both life-expectancy and quality of life and is intricately linked with cardiac and metabolic health - the cardio-kidney-metabolic multimorbidity syndrome. With early recognition of risk, chronic kidney disease can be prevented and with timely case-finding, early diagnosis and early intervention, its progression can be halted or slowed. The European Renal Association has established the Strong Kidneys Taskforce with the main purpose of creating awareness about the importance of kidney health for individual and population health. In collaboration with the European Kidney Health Alliance and the European Kidney Patients Federation, the ABCDE campaign will empower communities and individuals to remind their healthcare providers to assess their risk of kidney disease. ABCDE asks 5 simple questions about health status that only the healthcare system can provide: A) Do I have Albumin in my urine? B) What is my Blood pressure? C) What is my Cholesterol? D) Do I have Diabetes? E) What is my current kidney function (Estimated glomerular filtration rate)? This advocacy text aims to inform individuals, communities and front-line health care workers that capturing the risk of kidney, cardiac and metabolic health is simple, makes sense, is logical, and will save lives. Although making meaningful change will take time and involve major personal and societal changes the first step really is as easy as ABCDE!","PeriodicalId":19078,"journal":{"name":"Nephrology Dialysis Transplantation","volume":" ","pages":""},"PeriodicalIF":4.8,"publicationDate":"2025-03-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143663746","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Clonal Hematopoiesis of Indeterminate Potential: A Review of its Cardiorenal Implications and Aging.

IF 4.8 2区医学

Nephrology Dialysis Transplantation Pub Date : 2025-03-19 DOI: 10.1093/ndt/gfaf055

Abdullah Jalal, Kenar D Jhaveri, Raad B Chowdhury

{"title":"Clonal Hematopoiesis of Indeterminate Potential: A Review of its Cardiorenal Implications and Aging.","authors":"Abdullah Jalal, Kenar D Jhaveri, Raad B Chowdhury","doi":"10.1093/ndt/gfaf055","DOIUrl":"https://doi.org/10.1093/ndt/gfaf055","url":null,"abstract":"Clonal hematopoiesis of indeterminate potential (CHIP) is a non-malignant state characterized by hematopoietic stem cells exhibiting clonality driven by acquired mutations during aging. Using next generation sequencing (NGS), it has been reported that the prevalence of CHIP increases exponentially with age. Thus far, epigenetic mutations including DNMT3A, TET2, and ASXL1 are the most common mutations identified in driving CHIP. CHIP is considered a pre-malignant state, however with reports of its associations with non-malignant disease states, the clinical impact of CHIP has been of great interest, in particular its effect on the renal and cardiac systems. CHIP has been associated with a higher rate of estimated glomerular filtration rate (eGFR) decline and increased risk of acute kidney injury (AKI). CHIP and its driver mutations, have also been shown to increase cardiovascular disease and atherosclerosis through various inflammatory pathways. In this review, we discuss the pathophysiology of CHIP through aging, its impact on kidney disease, and implications on cardiovascular health. We also compare CHIP to another pre-malignant clonal disorder, monoclonal gammopathy of undetermined significance (MGUS).","PeriodicalId":19078,"journal":{"name":"Nephrology Dialysis Transplantation","volume":" ","pages":""},"PeriodicalIF":4.8,"publicationDate":"2025-03-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143663789","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Chemotherapy-related cognitive impairment and kidney dysfunction.

IF 4.8 2区医学

Nephrology Dialysis Transplantation Pub Date : 2025-03-13 DOI: 10.1093/ndt/gfae249

Mariadelina Simeoni, Michele M Mulholland, Biruh T Workeneh, Anna Capasso, Gaye Hafez, Sophie Liabeuf, Jolanta Malyszko, Laila-Yasmin Mani, Francesco Trevisani, Ananya De, Carsten A Wagner, Ziad A Massy, Robert Unwin, Giovambattista Capasso

{"title":"Chemotherapy-related cognitive impairment and kidney dysfunction.","authors":"Mariadelina Simeoni, Michele M Mulholland, Biruh T Workeneh, Anna Capasso, Gaye Hafez, Sophie Liabeuf, Jolanta Malyszko, Laila-Yasmin Mani, Francesco Trevisani, Ananya De, Carsten A Wagner, Ziad A Massy, Robert Unwin, Giovambattista Capasso","doi":"10.1093/ndt/gfae249","DOIUrl":"https://doi.org/10.1093/ndt/gfae249","url":null,"abstract":"Cancer and kidney diseases (KD) intersect in many ways resulting in worse outcomes. Both conditions are correlated with cognitive impairment, which can be exacerbated in cancer patients by known effects of many antineoplastic drugs on cognition, leading to a phenomenon known as chemotherapy-related cognitive impairment (CRCI). This manifests as poor attention span, disturbed short-term memory, and general mental sluggishness. This literature review explores CRCI and investigates the potential impact of KD on this phenomenon. Additionally, we highlight the shared pathogenetic mechanisms (including neurotoxicity, neuroinflammation, oxidative stress, vascular disease, electrolyte, and acid-base imbalances), clinical presentation and imaging findings between cognitive impairment in KD and CRCI. The disruption of the blood-brain barrier might be a key mechanism for increased brain permeability to anticancer drugs in nephropathic patients with cancer. Based on existing knowledge, we found a potential for heightened neurotoxicity of antineoplastic drugs and a synergistic potentiation of cognitive impairment in cancer patients with KD. However, further translational research is urgently required to validate this hypothesis.","PeriodicalId":19078,"journal":{"name":"Nephrology Dialysis Transplantation","volume":"40 Supplement_2","pages":"ii54-ii63"},"PeriodicalIF":4.8,"publicationDate":"2025-03-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143625246","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Big databases and biobanks for studying the links between CKD, cognitive impairment, and dementia.

IF 4.8 2区医学

Nephrology Dialysis Transplantation Pub Date : 2025-03-13 DOI: 10.1093/ndt/gfae255

Carmine Zoccali, Francesca Mallamaci, Kerry Rosenberg, Robert Unwin, Pedro Imenez Silva, Maria Adelina Simeoni, Gaye Hafez, Giovambattista Capasso, Dorothea Nitsch

{"title":"Big databases and biobanks for studying the links between CKD, cognitive impairment, and dementia.","authors":"Carmine Zoccali, Francesca Mallamaci, Kerry Rosenberg, Robert Unwin, Pedro Imenez Silva, Maria Adelina Simeoni, Gaye Hafez, Giovambattista Capasso, Dorothea Nitsch","doi":"10.1093/ndt/gfae255","DOIUrl":"10.1093/ndt/gfae255","url":null,"abstract":"Research on cognitive function in individuals with chronic kidney disease (CKD) is critical due to the significant public health challenge posed by both CKD and cognitive impairment. CKD affects approximately 10-15% of the adult population, with higher prevalence in the elderly, who are already at increased risk for cognitive decline. Cognitive impairment is notably higher in CKD patients, particularly those with severe stages of the disease, and progresses more rapidly in those on dialysis. This review explores how data from large biobank studies such as the Alzheimer's Disease Neuroimaging Initiative, UK Biobank, and others could be used to enhance understanding the progression and interplay between CKD and cognitive decline. Each of these data sources has specific strengths and limitations. Strengths include large sample sizes and longitudinal data across different groups, and in different settings. Addressing limitations leads to challenges in dealing with heterogeneous data collection methods, and addressing missing data, which requires the use of sophisticated statistical techniques. Combining data from multiple databases can mitigate individual study limitations, particularly via the 'epidemiological triangulation' concept. Using such data appropriately holds immense potential to better understand the pathobiology underlying CKD and cognitive impairment. Addressing the inherent challenges with a clear strategy is crucial for advancing our understanding and improving the lives of those affected by both CKD and cognitive impairment.","PeriodicalId":19078,"journal":{"name":"Nephrology Dialysis Transplantation","volume":"40 Supplement_2","pages":"ii37-ii45"},"PeriodicalIF":4.8,"publicationDate":"2025-03-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11905747/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143625226","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

The role of the intestinal microbiome in cognitive decline in patients with kidney disease.

IF 4.8 2区医学

Nephrology Dialysis Transplantation Pub Date : 2025-03-13 DOI: 10.1093/ndt/gfae253

Carsten A Wagner, Isabelle Frey-Wagner, Alberto Ortiz, Robert Unwin, Sophie Liabeuf, Yoko Suzumoto, Anna Iervolino, Alessandra Stasi, Vincenzo Di Marzo, Loreto Gesualdo, Ziad A Massy

{"title":"The role of the intestinal microbiome in cognitive decline in patients with kidney disease.","authors":"Carsten A Wagner, Isabelle Frey-Wagner, Alberto Ortiz, Robert Unwin, Sophie Liabeuf, Yoko Suzumoto, Anna Iervolino, Alessandra Stasi, Vincenzo Di Marzo, Loreto Gesualdo, Ziad A Massy","doi":"10.1093/ndt/gfae253","DOIUrl":"10.1093/ndt/gfae253","url":null,"abstract":"Cognitive decline is frequently seen in patients with chronic kidney disease (CKD). The causes of cognitive decline in these patients are likely to be multifactorial, including vascular disease, uraemic toxins, blood-brain barrier leakage, and metabolic and endocrine changes. Gut dysbiosis is common in patients with CKD and contributes to the increase in uraemic toxins. However, the gut microbiome modulates local and systemic levels of several metabolites such as short-chain fatty acids or derivatives of tryptophan metabolism, neurotransmitters, endocannabinoid-like mediators, bile acids, hormones such as glucagon-like peptide 1 (GLP1) or cholecystokinin (CCK). These factors can affect gut function, immunity, autonomic nervous system activity and various aspects of brain function. Key areas include blood-brain barrier integrity, nerve myelination and survival/proliferation, appetite, metabolism and thermoregulation, mood, anxiety and depression, stress and local inflammation. Alterations in the composition of the gut microbiota and the production of biologically active metabolites in patients with CKD are well documented and are favoured by low-fiber diets, elevated urea levels, sedentary lifestyles, slow stool transit times and polypharmacy. In turn, dysbiosis can modulate brain function and cognitive processes, as discussed in this review. Thus, the gut microbiome may contribute to alterations in cognition in patients with CKD and may be a target for therapeutic interventions using diet, prebiotics and probiotics.","PeriodicalId":19078,"journal":{"name":"Nephrology Dialysis Transplantation","volume":"40 Supplement_2","pages":"ii4-ii17"},"PeriodicalIF":4.8,"publicationDate":"2025-03-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11905753/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143625297","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

CONNECT: what has been done and what needs to be done.

IF 4.8 2区医学

Nephrology Dialysis Transplantation Pub Date : 2025-03-13 DOI: 10.1093/ndt/gfae248

Giovambattista Capasso, Robert J Unwin

引用次数: 0

Care pathways for patients with cognitive impairment and chronic kidney disease.

IF 4.8 2区医学

Nephrology Dialysis Transplantation Pub Date : 2025-03-13 DOI: 10.1093/ndt/gfae264

Marion Pépin, Konstantinos Giannakou, Hélène Levassort, Ana Farinha, Mickaël Bobot, Vincenzina Lo Re, Aleksandra Golenia, Jolanta Małyszko, Francesco Mattace-Raso, Aleksandra Klimkowcz-Mrowiec, Liliana Garneata, Evgueniy Vazelov, Elena Stepan, Giovanna Capolongo, Ziad Massy, Andrzej Wiecek

{"title":"Care pathways for patients with cognitive impairment and chronic kidney disease.","authors":"Marion Pépin, Konstantinos Giannakou, Hélène Levassort, Ana Farinha, Mickaël Bobot, Vincenzina Lo Re, Aleksandra Golenia, Jolanta Małyszko, Francesco Mattace-Raso, Aleksandra Klimkowcz-Mrowiec, Liliana Garneata, Evgueniy Vazelov, Elena Stepan, Giovanna Capolongo, Ziad Massy, Andrzej Wiecek","doi":"10.1093/ndt/gfae264","DOIUrl":"10.1093/ndt/gfae264","url":null,"abstract":"Various epidemiological datasets and pathophysiological hypotheses have highlighted a significant link between chronic kidney disease (CKD) and cognitive impairment (CI); each condition can potentially exacerbate the other. Here, we review the mutual consequences of CKD and CI on health outcomes and care pathways and highlight the complexities due to the involvement of different specialists. Our narrative review covers (i) the burden of CI among patients with CKD, (ii) the impact of CI on kidney health, (iii) access to kidney replacement therapy for people with CI, (iv) resources in cognitive care and (v) potential models for integrated 'nephro-cognitive' care. CI (ranging from mild CI to dementia) has a significant impact on older adults, with a high prevalence and a strong association with CKD. Furthermore, CI complicates the management of CKD and leads to a higher mortality rate, poorer quality of life and higher healthcare costs. Due to difficulties in symptom description and poor adherence to medical guidelines, the presence of CI can delay the treatment of CKD. Access to care for patients with both CKD and CI is hindered by physical, cognitive and systemic barriers, resulting in less intensive, less timely care. Multidisciplinary approaches involving nephrologists, geriatricians, neurologists and other specialists are crucial. Integrated care models focused on person-centred approaches, shared decision-making and continuous co-management may improve outcomes. Future research should focus on the putative beneficial effects of these various strategies on both clinical and patient-reported outcomes.","PeriodicalId":19078,"journal":{"name":"Nephrology Dialysis Transplantation","volume":"40 Supplement_2","pages":"ii28-ii36"},"PeriodicalIF":4.8,"publicationDate":"2025-03-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11905750/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143625234","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Genetic and circulating biomarkers of cognitive dysfunction and dementia in CKD.

IF 4.8 2区医学

Nephrology Dialysis Transplantation Pub Date : 2025-03-13 DOI: 10.1093/ndt/gfae259

Carmine Zoccali, Francesca Mallamaci, Carsten A Wagner, Robert Unwin, Maiken Nedergaard, Gaye Hafez, Jolanta Malyszko, Marion Pepin, Ziad Massy, Giuseppe Paolisso, Giuseppe Remuzzi, Giovambattista B Capasso

{"title":"Genetic and circulating biomarkers of cognitive dysfunction and dementia in CKD.","authors":"Carmine Zoccali, Francesca Mallamaci, Carsten A Wagner, Robert Unwin, Maiken Nedergaard, Gaye Hafez, Jolanta Malyszko, Marion Pepin, Ziad Massy, Giuseppe Paolisso, Giuseppe Remuzzi, Giovambattista B Capasso","doi":"10.1093/ndt/gfae259","DOIUrl":"10.1093/ndt/gfae259","url":null,"abstract":"Chronic kidney disease (CKD) is commonly accompanied by cognitive dysfunction and dementia, which, in turn, increase the risk of hospitalization, cardiovascular events and death. Over the last 30 years, only four studies focused on genetic markers of cognitive impairment in CKD and kidney failure (KF), indicating a significant gap in research. These studies suggest potential genetic predispositions to cognitive decline in CKD patients but also underscore the necessity for more comprehensive studies. Seventeen reports have established connections between cognitive function and kidney disease markers such as estimated glomerular filtration rate (eGFR), Cystatin C and albuminuria. A rapid eGFR decline has been associated with cognitive deterioration and vascular dementia, and mild to moderate eGFR reductions with diminished executive function in elderly men. Various biomarkers have been associated to Alzheimer's disease or dementia in CKD and KF. These include amyloid beta and phosphorylated tau proteins, uremic toxins, gut microbiota, metabolic indicators, hypertension, endothelial dysfunction, vitamins and inflammation. However, the causal relevance of these associations remains unclear. Overall, the available evidence points to a complex interplay between the different biomarkers and cognitive health in CKD patients, underscoring the need for more research to elucidate these relationships.","PeriodicalId":19078,"journal":{"name":"Nephrology Dialysis Transplantation","volume":"40 Supplement_2","pages":"ii64-ii75"},"PeriodicalIF":4.8,"publicationDate":"2025-03-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11905751/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143625279","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Cognitive impairment in kidney transplanted patients.

IF 4.8 2区医学

Nephrology Dialysis Transplantation Pub Date : 2025-03-13 DOI: 10.1093/ndt/gfae250

Jolanta Malyszko, Aleksandra Golenia, Michele Farisco, Vincenzina Lo Re, Aleksandra Klimkowicz-Mrowiec, Giovambattista Capasso, Dimitris Goumenos, Merita Rroji, Andreja Figurek, Gaye Hafez

{"title":"Cognitive impairment in kidney transplanted patients.","authors":"Jolanta Malyszko, Aleksandra Golenia, Michele Farisco, Vincenzina Lo Re, Aleksandra Klimkowicz-Mrowiec, Giovambattista Capasso, Dimitris Goumenos, Merita Rroji, Andreja Figurek, Gaye Hafez","doi":"10.1093/ndt/gfae250","DOIUrl":"10.1093/ndt/gfae250","url":null,"abstract":"Chronic kidney disease affects almost all of the organs. Recently, more attention has been paid to the kidney and the central nervous system connections. In patients on kidney replacement therapy, including kidney transplantation, there is an increased prevalence of cognitive impairment, and depression and other neurological complications, such as cerebrovascular disorders and movement disorders. Kidney transplant recipients need an assessment for the risk factors and the pattern of cognitive impairment (memory, attention and executive function decline). This enables an accurate diagnosis to be made at an earlier stage. Partial post-transplant cognitive impairment recovery is also important. Finally, doctors and patients alike face numerous ethical concerns and challenges regarding the transplantation of kidneys and other solid organs. In this review, we examined some key issues regarding cognitive impairment in kidney transplant patients. We focused on the mechanism of cognitive impairment in kidney transplant recipients, patterns of cognitive impairment; evaluation of patients with cognitive impairment for kidney transplantation, the potential impact of cognitive impairment on waitlisted and transplanted patients on patient care, non-pharmacological interventions and unmet medical needs, psychological and ethical issues in kidney transplantation, and unmet needs. As cognitive impairment in kidney transplant recipients is an underestimated, underrecognized but clinically relevant problem, screening for cognitive function before and after kidney transplantation would be worth considering in standard routine practice.","PeriodicalId":19078,"journal":{"name":"Nephrology Dialysis Transplantation","volume":"40 Supplement_2","pages":"ii46-ii53"},"PeriodicalIF":4.8,"publicationDate":"2025-03-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11905761/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143625290","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Cognitive impairment in chronic kidney disease: role of brain imaging, functional imaging, electroencephalography, cerebrospinal fluid biomarkers and sensors.

IF 4.8 2区医学

Nephrology Dialysis Transplantation Pub Date : 2025-03-13 DOI: 10.1093/ndt/gfae256

Alexandre Andrade, Maie Bachmann, Mickaël Bobot, Annette Bruchfeld, Ivo Fridolin, Laila-Yasmin Mani, Hong Xu

引用次数: 0